BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24166378)

  • 1. Cell-based bioluminescence screening assays.
    Amante RJ; Badr CE
    Methods Mol Biol; 2014; 1098():185-95. PubMed ID: 24166378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luminescence-based cell viability testing.
    Cree IA
    Methods Mol Biol; 1998; 102():169-77. PubMed ID: 9680619
    [No Abstract]   [Full Text] [Related]  

  • 4. High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.
    Danovi D; Folarin AA; Baranowski B; Pollard SM
    Methods Enzymol; 2012; 506():311-29. PubMed ID: 22341231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell sensitivity assays: the ATP-based tumor chemosensitivity assay.
    Glaysher S; Cree IA
    Methods Mol Biol; 2011; 731():247-57. PubMed ID: 21516413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lentiviral vector-based genetic sensor system for comparative analysis of permeability and activity of vitamin D3 analogues in xenotransplanted human skin.
    Staunstrup NH; Bak RO; Cai Y; Svensson L; Petersen TK; Rosada C; Stenderup K; Bolund L; Mikkelsen JG
    Exp Dermatol; 2013 Mar; 22(3):178-83. PubMed ID: 23489420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing.
    Brown CE; Wright CL; Naranjo A; Vishwanath RP; Chang WC; Olivares S; Wagner JR; Bruins L; Raubitschek A; Cooper LJ; Jensen MC
    J Immunol Methods; 2005 Feb; 297(1-2):39-52. PubMed ID: 15777929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
    Nogaki M; Ichihashi H
    Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis assays for quantifying the bioactivity of anticancer drug products.
    Brunelle JK; Zhang B
    Drug Resist Updat; 2010 Dec; 13(6):172-9. PubMed ID: 20947411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MTS vs. the ATP assay for in vitro chemosensitivity testing of primary glioma tumour culture.
    Dawson TP; Iyer RV; Lea RW; Roberts P; Harris E; Ashton K; Golash A; Davis CH
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):564-7. PubMed ID: 20524989
    [No Abstract]   [Full Text] [Related]  

  • 12. Luminescence applications for chemotherapeutic drug development.
    Andreotti PE; Caceres G; Zamkina R; Dauphinée M
    Recent Results Cancer Res; 2003; 161():3-12. PubMed ID: 12528794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicity and antitumor drug potential of platinum complexes.
    Sandman KE; Marla SS; Zlokarnik G; Lippard SJ
    Chem Biol; 1999 Aug; 6(8):541-51. PubMed ID: 10421759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of a thyroid hormone responsive reporter gene transduced into a Xenopus laevis cell line using lentivirus vector.
    Sugiyama S; Miyoshi H; Yamauchi K
    Gen Comp Endocrinol; 2005 Dec; 144(3):270-9. PubMed ID: 16102758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiplexed reporter gene assays: monitoring the cell viability and the compound kinetics on luciferase activity.
    Didiot MC; Serafini S; Pfeifer MJ; King FJ; Parker CN
    J Biomol Screen; 2011 Aug; 16(7):786-93. PubMed ID: 21693766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbioreactors for high-throughput cytotoxicity assays.
    Yang ST; Zhang X; Wen Y
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):111-27. PubMed ID: 18175274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional drug screening assay reveals potential glioma therapeutics.
    Badr CE; Wurdinger T; Tannous BA
    Assay Drug Dev Technol; 2011 Jun; 9(3):281-9. PubMed ID: 21184646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCD imaging of luciferase gene expression in single mammalian cells.
    Hooper CE; Ansorge RE; Browne HM; Tomkins P
    J Biolumin Chemilumin; 1990; 5(2):123-30. PubMed ID: 2336972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
    Jang SJ; Kang JH; Kim KI; Lee TS; Lee YJ; Lee KC; Woo KS; Chung WS; Kwon HC; Ryu CJ; Choi TH; Choi CW; Lim SM; Cheon GJ
    Cancer Lett; 2010 Nov; 297(1):84-90. PubMed ID: 20819721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.